← ANALYST RATINGS · TIPRANKS

Omada Health, Inc. (OMDA): analyst forecast and price target

$17.63 −5.57% close 16.10.26 · market cap $1.1B · General · Medical - Healthcare Information Services IWM 0.03%
Price targets and ratings of

Analyst consensus

Strong Buy

10 Buy1 Hold0 Sell

Ratings of 11 analysts in the last 3 months

12-month forecast

$28.27+60.4% upside

Based on 11 price targets given in the last 3 months, the average target is $28.27, the highest $35.00, the lowest $22.00. The average is +60.4% from the last price of $17.63.

$10.00$20.00$30.00Jan 26AprJulOctJan 27AprJulOctHigh$35.00Average$28.27Low$22.00
Highest target $35.00 Average target $28.27 Lowest target $22.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% Wells Fargo $22.00 Hold +24.8% Assigned 13.10.26on TipRanks Oct 14 05:30 −16.3%next day +0.6%
Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% Morgan Stanley $30.00 Buy +70.2% Reiterated 13.10.26on TipRanks 06:35 −16.3%next day +0.6%
Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% Morgan Stanley $30.00 Buy +70.2% Reiterated 28.09.26on TipRanks 07:45 −0.6%next day +0.1% · 5 days +6.8%
Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% Wells Fargo $22.00 Hold +24.8% Reiterated 14.09.26on TipRanks Sep 15 06:30 +4.7%next day −3.6% · 5 days −1.4%
Eugene Mannheimer★★★★★★★★★★#3417 · hits 51% · avg +6.8% Freedom Capital Markets $35.00 Buy +98.5% Reiterated 14.09.26on TipRanks 06:30 +4.7%next day −3.6% · 5 days −1.4%
Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% Evercore ISI $25.00 Buy +41.8% Reiterated 11.09.26on TipRanks 09:45 −9.4%next day +4.7% · 5 days +4.0%
Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% BMO Capital $24.00 Buy +36.1% Reiterated 11.09.26on TipRanks 07:55 −9.4%next day +4.7% · 5 days +4.0%
Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% Canaccord Genuity $28.00 Buy +58.8% Reiterated 11.09.26on TipRanks 07:30 −9.4%next day +4.7% · 5 days +4.0%
Ryan MacDonald★★★★★★★★★★#12366 · hits 37% · avg −11.1% Needham $28.00 Buy +58.8% Reiterated 11.09.26on TipRanks 06:50 −9.4%next day +4.7% · 5 days +4.0%
David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% BTIG $35.00 Buy +98.5% Assigned 11.09.26on TipRanks 05:55 −9.4%next day +4.7% · 5 days +4.0%
Saket Kalia★★★★★★★★★★#966 · hits 56% · avg +9.0% Barclays $25.00 → $27.00+8.0% Buy +53.1% Reiterated 11.09.26on TipRanks 05:15 −9.4%next day +4.7% · 5 days +4.0%
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $26.00 → $30.00+15.4% Buy +70.2% Reiterated 14.08.26on TipRanks 07:55 −1.2%next day −0.7% · 5 days +0.7%
Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% Citizens JMP $21.00 → $27.00+28.6% Buy +53.1% Reiterated 20.07.26on TipRanks 05:55 +1.0%next day −4.6% · 5 days −13.5%
David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% Goldman Sachs $26.00 → $25.00−3.8% Buy +41.8% Reiterated 10.06.26on TipRanks Jun 11 08:55 −5.1%next day +2.0% · 5 days −1.3%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Omada Health, Inc.

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Saket Kalia★★★★★★★★★★Barclays · #966
Hits 56%270 of 481 Average return +9.0%
1 year Saket Kalia★★★★★★★★★★Barclays · #966
Hits 56%270 of 481 Average return +9.0%
2 years Saket Kalia★★★★★★★★★★Barclays · #966
Hits 56%270 of 481 Average return +9.0%

Most profitable

3 months Elizabeth Anderson CFA★★★★★★★★★★Evercore ISI · #2664
Hits 55%210 of 382 Average return +4.4%
1 year Elizabeth Anderson CFA★★★★★★★★★★Evercore ISI · #2664
Hits 55%210 of 382 Average return +4.4%
2 years Elizabeth Anderson CFA★★★★★★★★★★Evercore ISI · #2664
Hits 55%210 of 382 Average return +4.4%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $28.27 at a price of $20.81 (+35.9%); now: $28.27 at $17.63 (+60.4%).

$20.00$25.00$30.00Sep 15Oct 1Oct 15Top analysts$29.17Average target$28.27Price$17.63

PriceAverage targetTop analysts’ target

Recommendation trend

010201101Oct 252121Nov312Dec9102Jan 26922Feb1453Mar1061Apr13112May891Jun6101Jul117Aug3211Sep4172Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy1386134
Buy11910172117
Hold211012
Sell000000

Earnings and sales forecast

Next report: 05.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.07 (from $-0.03 to $0.12). Last quarter: $0.18.

Sales

Next quarter’s sales estimate — $86M (from $84M to $86M). Last quarter: $88M.

Best top-analyst consensus in the sector · General

STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
About Omada Health, Inc.
  • CEO: Sean Duffy
  • Employees: 946
  • 611 Gateway Blvd, San Francisco, CA, 94080, US
  • www.omadahealth.com

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Data from the stock’s TipRanks forecast page, read 72 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗